user

Quality of life of elderly patients receiving weekly carboplatin and paclitaxel chemotherapy plus cetuximab first line for metastatic squamous cell carcinoma of the head and neck

被引：0
|
作者：
Lugini, A. [1 ]
Rossi, R. [2 ]
Pace, R. [1 ]
Rauco, A. [1 ]
Santarelli, M. [3 ]
Capparella, V. [1 ]
机构：
[1] San Camillo Lellis, Med Oncol Unit, Rieti, Italy
[2] Santa Maria Goretti, Med Oncol Unit, Rieti, Italy
[3] San Camillo Lellis, Radiotherapy Unit, Rieti, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3176
引用
收藏
页码：S752 / S752
页数：1
相关论文
共 50 条
  • [21] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chauffert, Bruno
    Zhou, Yuedan
    Medjkoune, Liza
    Ouikene, Abdenour
    Galez, Agnes
    Belkhir, Farid
    Saint-Germain, Pierre
    Youssef, Ali
    Chehimi, Mohamad
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
  • [22] WEEKLY REGIMEN OF PACLITAXEL-CARBOPLATIN-CETUXIMAB IN PATIENTS WITH RECURRENT SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCNH): RESULTS OF A MONOCENTRIC EXPERIENCE
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Restuccia, M. R.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 44 - 44
  • [23] PACLITAXEL/CARBOPLATINUM plus CETUXIMAB AS SECOND LINE CHEMOTHERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK CANCER
    Buentzel, J.
    Stritzel, R.
    de Vries, A.
    Muecke, R.
    Garayev, A.
    Bruns, F.
    Micke, O.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3224 - 3224
  • [24] Weekly paclitaxel/carboplatin and radiotherapy in inoperable squamous cell carcinoma of head & neck and lung
    Schmidt, P
    Heck, HK
    Preiss, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 874 - 874
  • [25] A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Bossi, P.
    Miceli, R.
    Locati, L. D.
    Ferrari, D.
    Vecchio, S.
    Moretti, G.
    Denaro, N.
    Caponigro, F.
    Airoldi, M.
    Moro, C.
    Vaccher, E.
    Sponghini, A.
    Caldara, A.
    Rinaldi, G.
    Ferrau, F.
    Nole, F.
    Lo Vullo, S.
    Tettamanzi, F.
    Hollander, L.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2820 - 2826
  • [26] Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Roy, C. Le
    Vernerey, D.
    Evin, C.
    Richard, S.
    Crespel, C.
    Samaille, T.
    Tourneau, C. Le
    Huguet, F.
    CLINICAL ONCOLOGY, 2022, 34 (12) : E473 - E481
  • [27] A comparison of cetuximab-containing regimens for recurrent/metastatic squamous cell head and neck carcinoma: the clinical significance of weekly paclitaxel and cetuximab
    Nakano, K.
    Marshall, S.
    Taira, S.
    Sato, Y.
    Tomomatsu, J.
    Sasaki, T.
    Shimbashi, W.
    Fukushima, H.
    Yonekawa, H.
    Mitani, H.
    Kawabata, K.
    Takahashi, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma
    Sheth, Siddharth
    Gilbert, Jill
    Deal, Allison Mary
    Chera, Bhishamjit
    Murphy, Barbara
    Woods, Justin
    Miller, Kelsey
    Weissler, Mark
    Hackman, Trevor
    Liao, Jay Justin
    Olson, Juneko Grilley
    Hayes, David Neil
    Weiss, Jared
    ORAL ONCOLOGY, 2022, 127
  • [29] Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma
    Yao, Zhuowei
    Wang, Jingshuo
    Jiang, Yongquan
    Zhang, Yi
    Liu, Jun
    Dai, Li
    Shen, Silin
    Zhou, Xiang
    Liu, Qiang
    Zheng, Luying
    Qian, Minfei
    Li, Jiping
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024,
  • [30] Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas
    Locke, Margaret
    Kohn, Nina
    Seetharamu, Nagashree
    CLINICAL OTOLARYNGOLOGY, 2023, 48 (06) : 915 - 919
12345